Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.35B.
ENTERPRISE VALUE (EV)
$2.35B
Clover Health Investments, Corp.
Market Cap
$2.43B
Enterprise Value (EV)
$2.35B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | $2.35B |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | $2.39B |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | $2.41B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | $2.02B |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | $1.92B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | $2.67B |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | $2.56B |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | $2.13B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | $5.08B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | $4.10B |
Market Cap
$2.43B
Total Debt
$0.00
Cash
$78.30M
Enterprise Value
$2.35B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
